Alebund Pharmaceuticals (jiangsu) Limited Class H (9637) Press Release
Documents on Display
Filed with HKEX ·
6ix hasn’t read this filing yet.
Alebund Pharmaceuticals (Jiangsu) Limited on 6ix
Earlier from Alebund Pharmaceuticals (Jiangsu)
Later from Alebund Pharmaceuticals (Jiangsu)
- List of directors and their roles and functions
- Announcement of final offer price and allotment results
- Alebund's AP301 NDA Accepted for Review by China's NMPA
- 2026 Interim report
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
Follow Alebund Pharmaceuticals (Jiangsu) into a list and get an email when it puts out news.
Follow Alebund Pharmaceuticals (Jiangsu)